SCOPUS 정보 검색 플랫폼

South African Family Practice

Volumn 55, Issue 6, 2013, Pages 511-514

Glucagon-like peptide 1 receptor agonists: A new approach to type 2 diabetes management

(1) Lambert, Lynn a

a Amayeza Info Services (South Africa)

Author keywords

GLP 1 receptor agonists; Type 2 diabetes

Indexed keywords

EXENDIN 4; GLUCAGON; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; HEMOGLOBIN A1C; INCRETIN; LIRAGLUTIDE; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADD ON THERAPY; ADJUVANT THERAPY; ARTICLE; BODY WEIGHT DISORDER; DIET THERAPY; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; DYSLIPIDEMIA; FOOD INTAKE; GLUCOSE HOMEOSTASIS; GLYCEMIC CONTROL; HUMAN; HYPERTENSION; HYPOGLYCEMIA; INSULIN RELEASE; LIFESTYLE MODIFICATION; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; STOMACH EMPTYING; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 84892408324 PISSN: 20786190 EISSN: 20786204 Source Type: Journal
DOI: 10.1080/20786204.2013.10874408 Document Type: Article

Times cited : (3)

References (8)

1
- 84855905976
- Choosing GLP-1 receptor agonists or DPP-4 inhibitors: Weighing the clinical trial evidence
- Reid T. Choosing GLP-1 receptor agonists or DPP-4 inhibitors: weighing the clinical trial evidence. Clin Diabetes. 2012;30:3-12.
- (2012) Clin Diabetes. , vol.30 , pp. 3-12
- Reid, T.¹

2
- 85029875367
- UpToDate [homepage on the Internet]. Available from
- Glucagon-like peptide-1-based therapies for the treatment of type 2 diabetes mellitus. UpToDate [homepage on the Internet]. c2013. Available from: http:// www.uptodate.com/contents/glucagon-like-peptide-1-based-therapies-for-thetreatment-of-type-2-diabetes-mellitus
- (2013) Glucagon-like peptide-1-based therapies for the treatment of type 2 diabetes mellitus.

3
- 79958265794
- Clinical efficacy of GLP-1 agonists and their place in the diabetes treatment algorithm
- Unger J. Clinical efficacy of GLP-1 agonists and their place in the diabetes treatment algorithm. J Am Osteopath Assoc. 2011;111(2 Suppl 1):eS2-eS9.
- (2011) J Am Osteopath Assoc. , vol.111 , Issue.2 SUPPL. 1
- Unger, J.¹

4
- 79955600633
- GLP-1 agonists and dipeptidyl-peptidase IV inhibitors
- Gallwitz B. GLP-1 agonists and dipeptidyl-peptidase IV inhibitors. Handb Exp Pharmacol. 2011(203):53-74.
- (2011) Handb Exp Pharmacol. , Issue.203 , pp. 53-74
- Gallwitz, B.¹

5
- 84865722751
- The 2012 SEMDSA guideline for the management of type 2 diabetes (revised)
- Amod A, Ascott-Evans BH, Berg GI, et al. The 2012 SEMDSA guideline for the management of type 2 diabetes (revised). JEMDSA. 2012;17(1):S1-S94.
- (2012) JEMDSA. , vol.17 , Issue.1
- Amod, A.¹ Ascott-Evans, B.H.² Berg, G.I.³

6
- 85053461543
- Haymarket Media Group
- Monthly Index of Medical Specialities. Haymarket Media Group, 2013.
- (2013) Monthly Index of Medical Specialities.

7
- 84892375893
- Byetta® package insert; 2008
- Byetta® package insert; 2008.

8
- 85029831390
- Medscape [homepage on the Internet]. Available from: Accessed 23/01/2013
- Recent advances in GLP-1 receptor agonists in the treatment of type 2 diabetes mellitus: a conference report from the 68th Scientific Sessions of the American Diabetes Association. Medscape [homepage on the Internet]. c2013. Available from: http://www.medscape.org/viewarticle/579731 Accessed 23/01/2013
- (2013) Recent advances in GLP-1 receptor agonists in the treatment of type 2 diabetes mellitus: A conference report from the 68th Scientific Sessions of the American Diabetes Association.

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.